Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02DKM
|
|||
| Former ID |
DNC010412
|
|||
| Drug Name |
Propan-2-one O-4-(hexyloxy)phenylcarbamoyl oxime
|
|||
| Synonyms |
CHEMBL597088; propan-2-one O-4-(hexyloxy)phenylcarbamoyl oxime
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H24N2O3
|
|||
| Canonical SMILES |
CCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C
|
|||
| InChI |
1S/C16H24N2O3/c1-4-5-6-7-12-20-15-10-8-14(9-11-15)17-16(19)21-18-13(2)3/h8-11H,4-7,12H2,1-3H3,(H,17,19)
|
|||
| InChIKey |
OTUAPVMKCJEVBD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.